{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:44Z","timestamp":1760060084521,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clindermatol.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T12:06:12Z","timestamp":1612267572000},"page":"418-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19: The Italian experience"],"prefix":"10.1016","volume":"39","author":[{"given":"Maria Letizia","family":"Musumeci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Nasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.01.013_bib0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/healthcare8020155","article-title":"Increased risk of COVID-19-related deaths among general practitioners in Italy","volume":"8","author":"Modenese","year":"2020","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.23736\/S0392-0488.20.06670-5","article-title":"Board Members of the SIDeMaST. The Italian dermatologic community facing COVID-19 pandemic: recommendation from the Italian society of dermatology and venereology","volume":"155","author":"Micali","year":"2020","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0003","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/jdv.16515","article-title":"Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice","volume":"34","author":"Gisondi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"year":"2021","series-title":"The early phase of the COVID-19 outbreak in Lombardy, Italy","author":"Cereda","key":"10.1016\/j.clindermatol.2021.01.013_bib0004"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jdermsci.2020.04.007","article-title":"Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the northern part of Italy","volume":"98","author":"Gianotti","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0006","doi-asserted-by":"crossref","first-page":"m1065","DOI":"10.1136\/bmj.m1065","article-title":"On the front lines of coronavirus: the Italian response to COVID-19","volume":"368","author":"Paterlini","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0007","doi-asserted-by":"crossref","first-page":"e13434","DOI":"10.1111\/dth.13434","article-title":"COVID-19 and psoriasis: should we fear for patients treated with biologics?","volume":"33","author":"Amerio","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0008","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/ijd.15059","article-title":"Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?","volume":"59","author":"Megna","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0009","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/ced.14245","article-title":"Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic","volume":"45","author":"Marasca","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0010","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/jdv.16529","article-title":"Skin cancer triage and management during COVID-19 pandemic","volume":"34","author":"Tagliaferri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0012","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1111\/jdv.16633","article-title":"A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?","volume":"34","author":"Skroza","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0013","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjd.19348","article-title":"Chilblain-like lesions during COVID-19 pandemic: a serological study on a case series","volume":"183","author":"Rizzoli","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0014","first-page":"e212","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0015","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1111\/jdv.16533","article-title":"Acral cutaneous lesions in the time of COVID-19","volume":"34","author":"Recalcati","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0016","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2020.04.044","article-title":"Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients","volume":"83","author":"Marzano","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0017","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/jdv.16774","article-title":"Cutaneous manifestations of SARS-CoV-2 infection: a clinical update","volume":"34","author":"Gisondi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0018","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1111\/jdv.16530","article-title":"Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome","volume":"34","author":"Tammaro","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2020.04.011","article-title":"Cutaneous manifestations of COVID-19: report of three cases and a review of literature","volume":"98","author":"Sachdeva","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0020","first-page":"e457","article-title":"Acute generalized exanthematous pustulosis with erythema multiforme-like lesions in a COVID-19 woman","volume":"34","author":"Robustelli Test","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0021","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1111\/jdv.16569","article-title":"Histological pattern in COVID-19 induced viral rash","volume":"34","author":"Zengarini","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0022","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1111\/jdv.16693","article-title":"COVID-19: how it can look on the skin. Clinical and pathological features in 20 COVID-19 patients observed in Bologna, north-eastern Italy","volume":"34","author":"Gaspari","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0023","doi-asserted-by":"crossref","first-page":"e13891","DOI":"10.1111\/dth.13891","article-title":"Colchicin treatment of COVID-19 presenting with cutaneous rash and myopericarditis","volume":"33","author":"Recalcati","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0024","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/jmv.26012","article-title":"Skin involvement in SARS-CoV-2 infection: case series","volume":"92","author":"Diotallevi","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0025","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1111\/jdv.16617","article-title":"Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient","volume":"34","author":"Locatelli","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0026","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ced.14267","article-title":"Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy","volume":"45","author":"Tosti","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1473-3099(20)30402-3","article-title":"Silent COVID-19: what your skin can reveal","volume":"21","author":"Guarneri","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0028","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/pde.14210","article-title":"Chilblains-like lesions in children following suspected COVID-19 infection","volume":"37","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0029","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1111\/jdv.16760","article-title":"An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient","volume":"34","author":"Negrini","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0030","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/dth.13544","article-title":"COVID-19 with dermatologic manifestations and implications: an unfolding conundrum","volume":"33","author":"Almutairi","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0031","doi-asserted-by":"crossref","first-page":"e13380","DOI":"10.1111\/dth.13380","article-title":"Generalized pustular figurate erythema. A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine","volume":"33","author":"Schwartz","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0032","doi-asserted-by":"crossref","first-page":"e13598","DOI":"10.1111\/dth.13598","article-title":"COVID-19 and impact of personal protective equipment use: from occupational to generalized skin care need","volume":"33","author":"Atzori","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0033","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1111\/jdv.16841","article-title":"Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy","volume":"34","author":"Talamonti","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.013_bib0034","doi-asserted-by":"crossref","first-page":"381","DOI":"10.23736\/S0392-0488.20.06807-8","article-title":"Back to work from the lockdown: recommendations from the Italian Society of Dermatology (SIDeMaST) and the Italian Forensic Dermatologic Society (SIDeLF)","volume":"155","author":"Monfrecola","year":"2020","journal-title":"G Ital Dermatol Venereol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:05Z","timestamp":1760033885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0738081X21000146"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.01.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19: The Italian experience","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}